The mite Varroa destructor is one of the most destructive parasites of the honey bee (Apis mellifera) and the primary cause of colony collapse in most regions of the world. These mites cause serious injury to their hosts, especially during the larval and pupal stages, and serve as the vector for several viruses, which affect honey bee health causing colony death. Attempts by beekeepers to control these mites have yielded limited success. The inability to rear populations of mites in vitro that excludes contact with their honey bee hosts has stymied research of Varroa biology. Previous attempts to rear and/or maintain Varroa mites in vitro by feeding them on artificial diets have had limited success. Several methods were plagued by mechanical failures including leaking membranes and, thus far, none have been widely adopted. Here we report a robust system for maintaining Varroa mites that includes an artificial diet, which does not contain honey bee tissue-derived components, thus making it particularly valuable in studying mite vectoring of honey bee viruses. With our system we demonstrated for the first time that Varroa mites maintained on an artificial diet supplemented with the particles of honey bee viruses, cDNA clone-derived genetically tagged Varroa destructor virus-1 and wild-type Deformed wing virus, can acquire and later transmit these viruses to recipient honey bee pupae. Along with providing an opportunity to study parasites and pathogens in the absence of honey bee hosts, this in vitro system for Varroa mite maintenance is both scalable and consistent. These features can be used to better understand mite nutritional needs, metabolic activity, responses to chemicals and other biological functions.
Introduction
The ectoparasitic mite, Varroa destructor (Anderson and Trueman) (Acari: Varroidae), is believed to be the major factor in the widespread collapse of honey bee colonies in North America as well as many parts of Europe and Asia [1] . Attempts by beekeepers to control Varroa mites have had only limited success [2, 3] . Consequently, there is a need to find new methods to control these parasites without harming the host bees. Unfortunately, efforts to gain a better understanding of the biology of Varroa have been stymied by the lack of a ready supply of mites along with a repeatable system for maintaining and/or rearing populations of mites for research purposes. Attempts to rear Varroa mites on liquid artificial diets have been the subject of intense investigation since the 1980's [4, 5] . Honey bee host pupae, the only life stage suitable for mite reproduction, are not available during the fall and winter in temperate areas, including most of the USA and Europe, and natural populations of Varroa mites do not arrive at sufficient levels needed for scientific studies until late summer [6] .
Successful rearing, or even long-term maintenance, of mite populations would greatly facilitate research on disease transmission, metabolism, reproduction, and the evaluation of control methods.
There have been several attempts to rear populations of Varroa mites in vitro using artificial diets. Perhaps the first successful attempt to feed Varroa on an artificial diet was reported by Bruce et al. [4] , who stretched a thin (~10 µm) parafilm membrane containing a dietary medium over modified queen cells, which are used for queen-rearing. Mites were observed to survive for up to 120 h, and many mites also laid eggs. However, this system was plagued by evaporation and contamination of the diet. Further modifications to this system using queen rearing cells covered with parafilm minimized leakage and were successful for maintaining a number of the much smaller tracheal mite, Acarapis woodi [7] . Later, Talbart et al. [5] produced synthetic chitosan membranes for holding an artificial diet with which to rear Varroa mites but this system also had limited success and has not yet been adopted by other researchers. This issue is likely due to earlier systems that required relatively complex components; only a few devices could be manufactured at a time, with the result that tests were done with very few mites [5, 8] . Attempts to reproduce these published methods revealed many setbacks (authors' unpubl. data), especially related to membrane leakage, which drowned the mites. These physical limitations made it difficult, if not impossible to carry out repeatable tests for research. Because a system for rearing populations of Varroa mites in vitro remains elusive, a system is still needed for maintaining sufficient numbers of mites for research purposes.
The success of maintaining Varroa mites on artificial diets for research purposes depends upon three major issues: 1) availability of numerous healthy adult female mites; 2) the composition of the artificial diet; and 3) a device and membrane system for housing mites and containing the diet, respectively. Unfortunately, sufficient numbers of Varroa mites for research remain seasonally restricted. Nonetheless, for further progress in maintaining large numbers of mites in vitro with artificial diets, the first task is to create a simple but reliable system that can allow mites housed in a device to have access to a diet that does not leak, evaporate or is prone to contamination [9] . The second task is to provide a membrane thin enough (10 to 15 µm), to allow Varroa mites to reach the diet with their mouthparts, which are very short [10] . Finally, methods must contain a sufficient volume of liquid to feed mites for many days or even weeks without compromising the quality and/or integrity of the diet.
In this report, we describe a robust system including a membrane based on that of Avila and colleagues [11] for maintaining large numbers of Varroa mites numbers on completely hostfree diets. Further, we validate the system's utility in an experiment of Varroa mite vectoring of honey bee viruses, specifically, the novel cDNA clone-derived Varroa destructor virus-1 (VDV1 or DWV-B).
Materials and Methods
V-BRL Diet. The artificial diet, hereafter termed the V-BRL (Varroa-Bee Research Lab) diet was based on Tabart et al. and Bruce et al. [4, 5] . Briefly, the diet included 30% Schneider's medium, 30% CMRL-1000, 1% Hanks salt solution (without NaCO 3, CaCl or MgSO 4 ), 10% bovine serum, 4% Insect medium supplement (cell culture type), 10% TC-100 Insect medium (with glutamine and NaCO 3 ) and 15% sterile water (all from Sigma-Aldrich, St. Louis MO).
To minimize contamination, fresh diet was prepared in a fume hood and stored frozen (-20 o C) in small aliquots. No antibiotics or antifungal agents were included to avoid compromising microbiota that may provide essential nutrients for mite nutrition, since species of Diplorickettsia, Arsenophonus, Morganella, Spiroplasma, Enterococcus, and Pseudomonas have been reported to inhabit Varroa mites [12] .
Varroa mites. The sugar roll method [13] was used to collect phoretic mites from honey bee colonies that had not received miticidal applications. Following collection, and after rinsing mites with tap water , they were placed on petri dishes lined with dry tissue paper. Mites were checked for activity prior to experimental selection, and only active mites used.
Device and membrane. Snap-cap polypropylene 1.5 mL microcentrifuge tubes were chosen for constructing the device housing the mites (Fig 1) . The tubes were cut crosswise at the point that allowed a 1 cm diameter opening. Cut surfaces were smoothed with sandpaper to avoid damaging the parafilm (American National Can Company, NY) membranes that would later be attached. Prior to using the devices, while wearing sterile nitrile gloves, containers were transferred to a laminar flow hood, disinfected for 2 min with 1.0 % bleach, followed directly by 6 light. Following disinfection and while still in the laminar flow hood, each device was covered with a thin sheet of sterilized parafilm stretched to 16.6±5.86 µm and wrapped over the open end of the device. Membrane thickness was checked with a Marathon digital micrometer (Marathon Corp., Canada). Diet solution (10 µL) was pipetted onto the center of the parafilm membrane, after which the membrane plus diet solution was covered with a second layer of sterile parafilm, forming the parafilm sachet [11, 14, 15] . The snap-cap lid on the other side of the device was opened to insert a female Varroa mite. Before closing, the lid was punctured with a sterile no. 1 stainless steel pin to form a minute hole (approximately 0.5 mm) to allow air to escape so the parafilm sachet would not rupture when the lid was snapped shut (Fig 1) . The completed devices were placed in a dark incubator (Thermofisher Scientific, San Jose, CA) set at 32.1 ± 0.3 °C, and having 82.2 ± 1.3 % relative humidity. A . B .
leakage of the diet, or whether air bubbles or other obstructions blocked access to the diet.
Finally, the diet was inspected for contamination and evaporation as described previously [9] .
Design of infectious cDNA clone of Varroa destructor virus-1 (VDV1 ) and production of clone-derived inocula. We designed a full-length infectious cDNA clone of a Californian isolate of VDV1, GenBank Accession number MN249174 (S1 Text, S2 Text). The cDNA had an introduced genetic marker, an AsiSI restriction site at the position 277 nt, which distinguished clone-derived VDV1 from wild-type VDV1 strains allowing us to trace transmission of this VDV1 isolate (S2 Text). The VDV1 cDNA clone and clone-derived infectious virus particles were produced using previously described approach [19] , and detailed in S1. In brief, the full-length cDNA clone of the virus was produced using total RNA from honey bees sourced from California in 2016 (isolate CA-07-2016) which showed high VDV1 and low DWV levels [20] ). Two overlapping cDNA fragments amplified by RT-PCR using specific primers, and the synthetic gene corresponding to the 277 nt 5' part of the genomic RNA were assembled in a plasmid vector (S1 Table; S1 Text). The resulting fulllength VDV1 cDNA plasmid construct was used to prepare the template for in vitro transcription. To produce clone-derived VDV1 inoculum, the purified in vitro RNA fulllength VDV1 transcript generated using the linearized VDV1 cDNA plasmid was injected into the hemolymph of purple eye honey bee pupae. Pupae were incubated 4 days at +33 o C (82.2 ± 1.3% relative humidity) to allow propagation of the clone-derived virus infection.
Tissue extracts containing the clone-derived VDV1 virus particles were collected by homogenizing infected pupae in PBS, and then filtering the supernatant through a 0.22μm nylon syringe filter (ThermoFisher, Waltham, MA) to remove host-derived cellular materials. The VDV1 extract introduced to the Varroa diet contained the clone-derived VDV1 (1.7 × 10 8 per µL) and background wild-type DWV derived from the recipient pupae (1.6 × 10 5 per µL), see S1 text for additional details. Transmission of the acquired viruses to honey bee pupae. Following the 36h acquisition period the surviving mites were placed individually on a pink-eyed honey bee pupa housed gelatin capsules and placed in a dark incubator (see above) for 48h to allow for the transmission of the virus to the pupae. Pupae were then incubated for an additional 72h to allow virus replication (Fig 2) . To determine whether viral transmission occurred, total RNA was extracted from each of pupae from the experimental (n=15) and control (n=9) treatment groups, then extracts subject to RT-qPCR to quantify copy numbers of VDV1 and DWV genomic RNA and assess transcription levels of honey bee actin by RTqPCR using the primers described in S1 Table as in [20] . To further demonstrate that VDV1 detected in the pupae derived from the clonal cDNA virus acquired by the mites from the artificial diet, the RT-PCR fragment corresponding to the 5' terminal 1200 nt was digested with the AsiSI restriction enzyme. The digested and undigested PCR fragments were separated by electrophoresis in 1.2 % agarose gel and visualized using ethidium bromide staining.
Acquisition of viruses by
Data analysis. The integrity of the device and diet were monitored and recorded using Zeiss
Axio camera attached to a stereoscopic microscope. The survival of the mites on the diet was analyzed using a Kaplan-Meier test (JMP, version 12, SAS, Cary, NC). Other variables included the number of fecal pellets deposited per day, and the number of viral replicates in pupae after Varroa mite transmission were analyzed using ANOVA or t-tests.
Results
Device, membrane and mite survival. The feeding device (Fig 1) allowed Varroa mites to feed on the artificial diet without honey bee-derived components through a ~10 µm parafilm membrane. No evidence of diet leakage, evaporation or contamination, or other mechanical failures precluding mite's access to the diet was recorded. We compared survival of mites from the three trials having devices with parafilm sachets containing the V-BRL artificial diet against survival of mites from both the positive and negative control groups (Fig 3; S2 Table) . In contrast to diet fed-mites, most mites survived up to 25 days while feeding on bee pupae. Mite survival declined precipitously after day 10. The average survival time while feeding on pupae was 9.42 days (Fig 3, green dotted line). We found that mites began dying within 6h after confinement in the artificial feeding device without diet. Of the 32 mites held in the container without food (negative control group), all but two were dead within one day; the remaining two died by day two (Fig 3, black dotted line) . Notably, mites incubated in the devices containing water deposited only minute amounts of excreta, indicating a lack of feeding. Contrary to poor survival by the mites in devices containing water (mean survival time ± standard error: 1.06 ± 0.04 days), mites survived for significantly long periods when kept in the devices containing diet (Fig 3, solid lines) .
Three trials each involving 10 diet chambers, involving 30 to 42 mites in total in each trial, were carried out ( Fig 3, Table 1 ; S2 Table) , with mean survival times ± standard error for three trials were 1.70 ± 0.12, 2.35 ± 0.35, and 2.07 ± 0.20 days. In the first trial, mites Table) and the finding of FITC-labeled fluorescent beads in excreta of the mites fed on the bead-containing diet (Fig 4B) but not in excreta for those feeding diet without fluorescent beads (Fig 4 C) . The daily average deposition of excreta was 2.55 ± 0.52 deposits per mite. Statistical analysis of the excreta data for each of the four days showed that the differences in excreta per live mite per day were not statistically significant (one-way 
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Evidence of acquisition of viruses by mites and transmission to honey bee pupae.
There was no statistically significant difference in the survival of mites fed on the diet containing the viruses versus mites fed on the control diet over a 72-h study period (S1 Fig,   S4 Table, S5 Table) . While there was no significant difference between the levels of honey bee actin mRNA in the treatment and control groups (P=0.1395, S6 Table) , the levels of DWV and VDV1 were statistically significantly higher in pupae exposed to virus-fed mites compared to those in the control group (P<0.01 and P<0.001 respectively; Fig 5A) . effect size). Importantly, high levels of DWV and VDV1 exceeding 10 9 virus copies per pupa, were observed only in the treatment group. High levels of VDV1 were observed in 7 of 15 pupae of the treatment group pupae, while only one pupa developed high DWV levels in the control (Fig 5A) . This result could be explained by a 1000-fold difference between the levels of DWV and VDV1 in the diets containing 3.2 × 10 4 and 3.3 × 10 7 genome equivalent per µL respectively.
We confirmed that VDV1 derived from the artificial diet replicated in the treatment group pupae to high levels based on the diagnostic AsiSI restriction site (Fig 5B) . This restriction site was not present in the wild-type isolates of VDV1 or DWV (Fig 5B, lane "wt"). Further evidence showing that the VDV1 transmitted to pupae was the cDNA clone VDV1 acquired from the artificial diet comes from digesting the RT-PCR fragment corresponding to the 5' terminal 1200 nt with AsiSI restriction enzyme. All seven of the recipient pupae that developed high virus levels showed that the AsiSI site was present in VDV1 ( Fig 5B) . Notably, the sample isolated from the 27 pupae of the treatment group contained high levels of both DWV and VDV1 (Table S5 ), but only VDV1 was digested as agarose gel analysis showed (Fig 5B, lane 27) . amplified with the primers specific to both DWV and VDV1 using RNA extracts from the experimental pupae with the virus levels exceeding 10 9 genome copies from the "Virus extract" group (S6 Table) , and from the wild-type VDV1 and DWV-infected pupae, "wt".
The undigested 1250 nt fragments (left) and AsiSI-digested (right). Expected fragment sizes, undigested (black arrow) and AsiSI-digested (red arrows), are shown on the left, DNA ladder sizes are shown on the right.
Discussion
Here we describe a simple, but robust, system including an artificial diet, which was free of honey bee-derived components, that successfully maintained Varroa mites for a study of their vectoring of honey bee viruses to host pupae. In contrast to the previous artificial systems for rearing/maintaining Varroa mites, we used the accumulation of mite excreta and the presence of the fluorescent microbeads acquired from the diet in the excreta to confirm that mites had successfully fed through the membrane on the artificial diet. With this system, many mites survived consistently for 4 days (rarely, 7 days Posada et al unpublished), and an average longevity for up to five days, which is similar to the longevity of mites reported using other artificial systems [5] . The finding of live mites and excretory pellets on the parafilm membranes strongly suggests that the mites were feeding repeatedly on the diet, similar to the numerous excretory pellets found by Egekwu et al [18] for mites surviving on honey bee pupae. Notably, the greatest number of excretory deposits were found in the devices in which the mites survived the longest as supported by finding FITC-labeled fluorescent beads in the mite excreta. These findings show that Varroa mites can not only survive on the artificial diet, but also can remain vigorous and suitable for experiments of viral transmission such as the current study showing virus acquisition and transmission from diet to pupae. Thus, the important question was not whether mites survived for long periods like those fed exclusively on pupae [18], but whether enough mites fed and survived during the period of the experiments in which they were used.
Our results with using the novel cDNA clone of genetically-tagged VDV1 also show that the acquisition period of 36 h was sufficient for Varroa mites feeding on the artificial diet to acquire sufficient numbers of viral particles to transmit them to the honey bee pupae, wherein they proliferated to high levels. No viral transmission to host pupae occurred subsequent to mites feeding on the control diet supplemented only with fluorescent beads.
Although the results of our study showing viral transmission to honey bees by Varroa mites is not novel, here we show for the first time that virus particles of clonal VDV1 and DWV remained infectious in the artificial V-BRL diet long enough to be acquired by Varroa mites and subsequently transmitted to honey bee host pupae.
A significant challenge in this experiment was potential presence of viruses in both the recipient honey bee pupae and the Varroa mites sourced from the honey bee colonies maintained in apiaries known to harbor viruses. Therefore, it was also necessary to distinguish between the virus introduced through feeding on the diet and those that may have already been present either in the mites or in the recipient honey bee pupae. This challenge was resolved by using cDNA clone-derived VDV1 (also known as DWV-B) that was tagged with a rare AsiSI restriction enzyme site to differentiate it from the wild type ( Fig 5B) . The absence of pupae with high DWV and VDV1 levels (above 10 9 genome equivalents) in the control group (Fig 5A) , i.e. by mites exposed to 36 h feeding on virus-free diet, was in agreement with the recent report by which indicated that DWV is vectored by Varroa mites via a non-persistent mechanical route [17] .
The virus acquisition and subsequent transmission experiment presented in this report provides a "proof of concept" that validates the utility of the in vitro system for maintaining 
RT-PCR amplification of the VDV1 and DWV IRES sequence, positions 30-49 of VDV1 genomic RNA.
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